Kinnevik AB (publ)
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed April 15, 2024), Kinnevik AB (publ) reported 1 stock position worth $103.7 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 100.0% of the portfolio. Its holdings were unchanged from Q4 2023.
- Most Recent 13F
- Q3 2025
- Location
- STOCKHOLM, V7
- CIK
- 0001766574
- Portfolio Value
- $103.7M (Q1 2024)
- SEC Filing
- 0001104659-24-047278 ↗ filed Apr 15, 2024
Holdings Value
Holdings 1 stocks · $103.7M
| RXRX Recursion Pharmaceuticals-A | 100.00% | 10,405,668 | $103.7M | No change |
Portfolio Sells Q4 2023 → Q1 2024
| None this quarter. | |||
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||